Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Blue Nevi and Related Tumors
1Lahey Clinic, 41 Mall Road, Burlington, MA 018056, USA; www.DermatopathologyConsultations.com, C/O Harvard Vanguard Medical Associates Laboratories, 152 2nd Avenue, Needhan, MA 02494, USA.
Blue nevi, including common, cellular, and atypical types, originate from neural crest cells. Genetic mutations in GNAQ and GNA11 are key, with additional changes driving malignant blue nevus progression.
Area of Science:
- Dermatopathology
- Molecular Biology
- Developmental Biology
Background:
- Blue nevi are melanocytic lesions originating from neural crest cells.
- Key subtypes include common blue nevus, cellular blue nevus, atypical blue nevus, and malignant blue nevus.
- These lesions are characterized by dermal pigmented dendritic melanocytes.
Purpose of the Study:
- To review recent advances in the pathology of blue nevi.
- To emphasize differential diagnosis and molecular pathology of blue nevi.
- To discuss the genetic underpinnings of blue nevus development and malignant transformation.
Main Methods:
- Review of current literature on blue nevus pathology.
- Analysis of genetic mutations associated with blue nevi.
- Discussion of histopathological features for differential diagnosis.
Main Results:
- Blue nevi arise from melanocytes, Schwann cells, and glial cells from the ventral neural crest.
- Common genetic drivers include mutations in GNAQ and GNA11.
- Malignant blue nevus progression involves additional mutations and chromosomal aberrations.
Conclusions:
- Understanding the molecular pathology of blue nevi is crucial for diagnosis and management.
- Differential diagnosis relies on distinguishing benign from atypical and malignant variants.
- Advances in molecular pathology offer insights into the pathogenesis of blue nevi.
More Related Videos
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...